10 likes | 123 Views
Publications en langue anglaise. Procare The Procare group . Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the procare Study. BCF 2000 ;11: 511-518.
E N D
Publications en langue anglaise • Procare • The Procare group. Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the procare Study. BCF 2000;11: 511-518. • The Procare group. Venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation from symptomatic families: any role for hormonal replacement? JTH 2003 ; 1 : p 1325 • The Procare group. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients? BCF 2003 ; 14 : 523-9. • The Procare group. Risk of venous thromboembolism during pregnancy in homozygous carriers of the factor V Leiden mutation: are there any predictive factors? JTH 2004 ; 2: p 359-60. • The Procare group - GEHT (étude multicentrique coordonnée par C Biron-Andréani). Influence of genetic polymorphisms and ABO blood group on the risk of venous thrombosis in factor V Leiden homozygotes : Study of 180 subjects. BJH 2006;135:697-702. • Biron-Andréani C et al on behalf PROCARE-GEHT. The relationship between the Factor V Leiden homozygous genotype and pregnancy outcomes. Obst Gynecol 2009;114: 1249-53. • TIH / refludan • Tardy B et al GEHT-HIT Study Group. Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.Blood 2006 1;108:1492-6